CAMP4 Therapeutics Corp. (CAMP)
4.50
+0.06
(+1.35%)
USD |
NASDAQ |
Jan 21, 16:00
4.41
-0.09
(-2.00%)
Pre-Market: 20:00
CAMP4 Therapeutics EPS Diluted (Quarterly): -0.5536 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Pfizer Inc. | 0.6197 |
| Vor Biopharma, Inc. | -121.63 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.10M |
| Revenue (Quarterly) | 0.795M |
| Total Expenses (Quarterly) | 15.89M |
| Enterprise Value | 142.06M |
| Gross Profit Margin (Quarterly) | 47.67% |
| Profit Margin (Quarterly) | -1.90K% |
| Earnings Yield | -54.54% |
| Normalized Earnings Yield | -53.23 |